California Public Employees Retirement System lifted its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 6.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 86,240 shares of the company’s stock after purchasing an additional 5,040 shares during the quarter. California Public Employees Retirement System owned about 0.23% of Omnicell worth $4,403,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Flinton Capital Management LLC raised its stake in shares of Omnicell by 74.6% during the second quarter. Flinton Capital Management LLC now owns 4,216 shares of the company’s stock valued at $182,000 after purchasing an additional 1,802 shares in the last quarter. Riverhead Capital Management LLC raised its stake in shares of Omnicell by 76.3% during the second quarter. Riverhead Capital Management LLC now owns 4,230 shares of the company’s stock valued at $182,000 after purchasing an additional 1,830 shares in the last quarter. Pinebridge Investments L.P. raised its stake in shares of Omnicell by 1.6% during the second quarter. Pinebridge Investments L.P. now owns 4,896 shares of the company’s stock valued at $211,000 after purchasing an additional 76 shares in the last quarter. Amalgamated Bank bought a new stake in shares of Omnicell during the second quarter valued at about $219,000. Finally, Stevens Capital Management LP bought a new stake in shares of Omnicell during the third quarter valued at about $305,000. Institutional investors and hedge funds own 99.61% of the company’s stock.
A number of equities research analysts recently weighed in on OMCL shares. Zacks Investment Research cut shares of Omnicell from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 1st. Oppenheimer restated a “buy” rating and set a $55.00 price objective on shares of Omnicell in a research note on Tuesday, December 5th. Craig Hallum reiterated a “buy” rating and issued a $62.00 price target (up from $52.00) on shares of Omnicell in a research report on Monday, October 30th. Cantor Fitzgerald boosted their price target on shares of Omnicell to $58.00 and gave the stock an “overweight” rating in a research report on Friday, October 27th. Finally, BidaskClub cut shares of Omnicell from a “hold” rating to a “sell” rating in a research report on Friday, December 22nd. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $55.14.
Shares of Omnicell, Inc. (NASDAQ:OMCL) opened at $50.40 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. Omnicell, Inc. has a 1 year low of $32.35 and a 1 year high of $55.40. The company has a market cap of $1,925.07, a PE ratio of -458.18, a price-to-earnings-growth ratio of 4.03 and a beta of 0.71.
Omnicell (NASDAQ:OMCL) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The firm had revenue of $186.78 million for the quarter, compared to analysts’ expectations of $192.45 million. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. Omnicell’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.40 earnings per share. equities analysts anticipate that Omnicell, Inc. will post 0.12 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This news story was first published by BBNS and is the property of of BBNS. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/omnicell-inc-omcl-position-boosted-by-california-public-employees-retirement-system/1822142.html.
Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.